Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128542) titled 'Efficacy and Safety of Levetiracetam Sustained-release Granules in the Treatment of Focal Epilepsy: A Prospective, Multicenter, Real-world Observational Study' on July 22.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shanghai General Hospital
Condition:
epilepsy
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-25
Target Sample Size: Levetiracetam sustained-release granules treatment group:116;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=326907
Disclaimer: Curated by HT Syndication....